868360-65-0

Basic information

• Product Name: 6-(2-furyl)-1-(4-methoxybenzyl)-5-pyrimidin-4-yl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one
• Synonyms: 6-(2-furyl)-1-(4-methoxybenzyl)-5-pyrimidin-4-yl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one
• CAS NO: 868360-65-0
• Molecular Weight: 399.409
• Mol File: 868360-65-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-(2-furyl)-1-(4-methoxybenzyl)-5-pyrimidin-4-yl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(2-furyl)-1-(4-methoxybenzyl)-5-pyrimidin-4-yl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one(868360-65-0)
• EPA Substance Registry System: 6-(2-furyl)-1-(4-methoxybenzyl)-5-pyrimidin-4-yl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one(868360-65-0)

Safety Data

• Hazardous Substances Data: 868360-65-0(Hazardous Substances Data)

Upstream product

• 868360-50-3 methyl 2-chloro-6-(2-furyl)-5-pyrimidin-4-ylnicotinate 
• 140-69-2 4-methoxybenzylhydrazine 

Relevant articles and documents

CONDENSED PYRIDINE DERIVATIVES USEFUL AS A28 ADENOSINE RECEPTOR ANTGONISTS

The present invention relates to new antagonists of the A2B adenosine receptor represented by formula (I). Those compounds are useful for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by antagonism of the A2B adenosine receptor such as asthma, bronchoconstriction, allergic diseases, hypertension, atherosclerosis, reperfusion injury, myocardial ischemia, retinopathy, inflammation, gastrointestinal tract disorders, cell proliferation disorders, diabetes mellitus, and/or autoimmune diseases.